(ARVN) |
0 (0%) 10-10 07:12 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 11.78 |
Resistance 1: | 10.08 |
Pivot price: | 8.64 |
Support 1: | 8.39 |
Support 2: | 7.35 |
52w High: | |
52w Low: |
EPS | -1.010 |
Book Value | 8.320 |
PEG Ratio | 0.00 |
Gross Profit | 5.339 |
Profit Margin (%) | -19.47 |
Operating Margin (%) | -314.73 |
Return on Assets (ttm) | -6.7 |
Return on Equity (ttm) | -12.0 |
Thu, 09 Oct 2025
Weiss Ratings Reiterates Sell (E+) Rating for Arvinas (NASDAQ:ARVN) - MarketBeat
Tue, 07 Oct 2025
Piper Sandler Maintains Arvinas(ARVN.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛
Tue, 07 Oct 2025
Arvinas Holding Company (ARVN) Receives a Hold from Bank of America Securities - The Globe and Mail
Sun, 05 Oct 2025
Arvinas (ARVN) Highlights Promising Phase 1 Trial Results for AR - GuruFocus
Sun, 05 Oct 2025
97% LRRK2 Reduction — Arvinas' ARV-102 Shows Strong PBMC Target Engagement and CSF Biomarker Modulation - Stock Titan
Wed, 01 Oct 2025
$ARVN stock is up 8% today. Here's what we see in our data. - Quiver Quantitative
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |